Pearls and pitfalls: Neurostimulation in headache

  title={Pearls and pitfalls: Neurostimulation in headache},
  author={Tim Patrick J{\"u}rgens and Massimo Leone},
  pages={512 - 525}
Context A variety of neuromodulatory approaches available today has broadened our therapeutic options significantly especially in drug refractory patients with chronic cluster headache and chronic migraine. Overview It is a dynamic field with a current trend to non-invasive transcutaneous stimulation approaches. However, sound studies providing evidence for the widespread use of these novel approaches are sparse. For invasive approaches, occipital nerve stimulation is now widely considered the… 

Figures and Tables from this paper

Neuromodulation in primary headaches: current evidence and integration into clinical practice.

This review provides a comprehensive overview of current controlled studies on the different neuromodulation techniques and recommendations for clinical practice, with a focus on transcutaneous and supraorbital nerve stimulation.

Advanced technologies and novel neurostimulation targets in trigeminal autonomic cephalalgias

New neurostimulation technologies using less invasive or non-invasive approaches and modulating different neuroanatomical targets have been recently studied, demonstrating the efficacy of central and peripheral neuromodulation approaches for management of patients with refractory TACs.

Stimulation of the sphenopalatine ganglion in intractable cluster headache: Expert consensus on patient selection and standards of care

Standard of care based on expert consensus are proposed to ensure homogeneous patient selection and treatment across international headache centres to ensure maximal efficacy and safety of high-frequency sphenopalatine ganglion stimulation.

Peripheral Neuromodulation on the Refractory Headache Disorders

In the field of chronic headache, there are a high number of patients with failure of pharmacological treatment; in these cases neuromodulation would have a remarkable role and noninvasive methods that could serve as useful adjuncts to more conventional therapies are reviewed.

[Neuromodulation in primary headache in the year 2019: is it still up-to-date? : New data on invasive and non-invasive neuromodulation in migraine and cluster headaches].

This article critically reviews the literature focussing on recent controlled studies, provides recommendations on their use in clinical practice and strives to integrate them into present treatment regimes.

Non-Invasive Neurostimulation Methods for Acute and Preventive Migraine Treatment—A Narrative Review

  • S. Evers
  • Medicine
    Journal of clinical medicine
  • 2021
In the future, it is very important to conduct large, properly blinded and controlled trials performed by independent researchers Otherwise, neurostimulation methods will only play a very minor role in the treatment of migraine.

Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study

Non-invasive vagus nerve stimulation may be effective as acute treatment for HFEM or CM and may help to reduce medication overuse and medication-associated adverse events.

Nociception specific supraorbital nerve stimulation may prevent cluster headache attacks: Serendipity in a blink reflex study

  • D. HaaneP. Koehler
  • Medicine, Psychology
    Cephalalgia : an international journal of headache
  • 2014
Bilateral, time contingent, nociception specific, transcutaneous supraorbital nerve stimulation may have a prophylactic effect in episodic and chronic cluster headache.

Methodological Difficulties in Clinical Trials Assessing Neuromodulation Devices in the Headache Field

  • M. BarloeseG. Lambru
  • Medicine, Psychology
    Neuromodulation in Headache and Facial Pain Management
  • 2019
No clear consensus has been agreed on how clinical trials in neuromodulation should be conducted, and common reporting standards are lacking, and considerable heterogeneity in the methodology applied in published trials represents a significant obstacle in the attempt to compare outcomes.

Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial

A preliminary evaluation of the efficacy of the Cefaly® device for the prophylaxis of chronic migraine with or without medication overuse and over half the patients had a greater than 50% reduction in acute medication consumption.



Neurostimulation approaches to primary headache disorders

This review summarizes the current concepts, approaches and outcome data of invasive device-based neurostimulation approaches using occipital-nerve stimulation and deep-brain stimulation to further elucidate the clinical potential of neuro Stimulation in chronic headache.

Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: Initial experience

Combined occipital nerve–supraorbital nerve neurostimulation systems may provide effective treatment for patients with chronic migraine and refractory chronic migraine headaches.


Preliminary success suggests a role for posterior hypothalamic stimulation as a safe and effective treatment in patients with medically refractory CPH, and contributes to results of studies that support a central pathophysiological role for hypothalamic dysfunction in headaches classified among the trigeminal autonomic cephalgias.

Feasibility of simultaneous vagal nerve and deep brain stimulation in chronic cluster headache: case report and considerations

The case of a patient with chronic cluster headache (CCH) who had initially improved after DBS, whose clinical effect subsequently diminished after head trauma is reported, thus obtaining a new 50% reduction in frequency of pain bouts.

Neurostimulation for Primary Headache Disorders: Part 2, Review of Central Neurostimulators for Primary Headache, Overall Therapeutic Efficacy, Safety, Cost, Patient Selection, and Future Research in Headache Neuromodulation

Overall therapeutic efficacy, safety, cost, patient selection, and recommendations for further research of neurostimulation modalities based on available data are analyzed.

Central modulation in cluster headache patients treated with occipital nerve stimulation: an FDG-PET study

Metabolic normalization in the pain neuromatrix and lack of short-term changes induced by the stimulation might support the hypothesis that ONS acts in drCCH through slow neuromodulatory processes.

Hypothalamic stimulation for trigeminal neuralgia in multiple sclerosis patients: efficacy on the paroxysmal ophthalmic pain

Deep brain stimulation may be considered as an adjunctive procedure for treating refractory paroxysmal pain within the first trigeminal division so as to avoid the complication of corneal reflex impairment that is known to follow ablative procedures.

Treatment of refractory chronic cluster headache by chronic occipital nerve stimulation

The data confirmed the results of the 36 similar cases reported in the literature, suggesting that ONS may act as a prophylactic treatment in chronic CH, and should be proposed before deep brain stimulation in severe refractory CCH patients.